Local Representative of MA Holder






      Megainpharm GmbH has ample experience in the field of commercial release of medicinal products. Positioning of our headquarters in Vienna, Austria allows for easy cooperation with leading pharmaceutical distributors and pharmacy chains operating in the European Union. Thereby, we can offer our services as local representative of Marketing Authorization holder. Our team of experts design the most effective distribution plans, with respect to product’s specificities, existing laws and regulations and reference documents. Our expertise and proactive approach allow to design a distribution strategy in a way that assures the most profit without cost overrun.

Local Representative of MA Holder 


Local Representative of MA Holder 

Acting as local representative, Megainpharm GmbH facilitates the entrance to most profitable and active markets that ensure highest profit margins. Moreover, our company provide support and services in brand management and product promotion in selected markets for assuring high sales. Additionally, as local representative, Megainpharm GmbH can participate in pharmacovigilance and marketing study in order to assure stable sales, reveal and prevent different adverse effects related to drug administration by patients. It implies collection and processing of data received from patients and legal entities on all adverse effects related to drug administration for the intended purpose in accordance with the instruction for medical use. Under certain circumstances, in case of an especially adverse effect, an investigation can be commenced in order to detect the root cause of its exposure. Abovementioned activities require united efforts of commercial and scientific personnel in order to conduct investigation most accurately and minimize reputational losses.



Megainpharm GmbH offers the following services for our clients:

  • Informational support on pharmaceuticals distribution;
  • Interaction with competent authorities of the EU to obtain appropriate distribution authorization;
  • Design, implementation and control of medicinal product distribution strategy;
  • Development of distribution network;
  • Market monitoring within risk management system;
  • Brand management strategy development;
  • Management of pharmacovigilance system and related arrangements.